Aurobindo recalling over 4,600 bottles of pain relieving tablets in U.S.
Generic drugmaker Aurobindo Pharma is recalling 4,608 bottles of pain relieving drug Acetaminophen Tablets, 325 mg, in the U.S.
They are 100-count bottles and being recalled due to deviations from current Good Manufacturing Practices (cGMP), the U.S. Food and Drug Administration (U.S. FDA) said. Specially it is 'due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets),' the regulator said in its latest enforcement report.
It is a voluntary recall and initiated by Aurobindo Pharma USA Inc., a subsidiary of the Hyderabad-based drugmaker, on May 22.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Neglected and forgotten: Psychiatric patients face systemic apathy in Hyderabad; implement Mental Health Act fully, say experts
A food poisoning incident at Institute of Mental Health, Erragadda, exposed the plight of psychiatric patients HYDERABAD: The food poisoning incident at the govt-run Institute of Mental Health (IMH), Erragadda, earlier this month highlighted the condition of psychiatric patients in the state. Although a state mental health authority (SMHA) has been established, mental health experts say that it is yet to completely implement the provisions of the Mental Health Act, 2017, across Telangana. The act was introduced to ensure that such individuals receive quality mental healthcare and are treated with dignity. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad The state mental health authority's role includes creating awareness about mental health and illness to reduce the stigma associated with mental illness, as well as providing legal aid. M Srinivas, president of the Hyderabad-based Network of Persons with Disabled Organisation (NPdO), claimed the SMHA is only working towards the physical well-being of psychiatric patients, neglecting their societal reintegration. "Many patients have been abandoned by their families, and their rehabilitation is happening only for the namesake. As per the act, rehabilitation services should be closer to the patient's residence, but most are forced to travel to Hyderabad. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 'They Want This Joint Relief Gummy Gone—Here's Why Seniors Love It' Joint Fuel 360 Click Here Undo The properties of several of these patients are in dispute owing to their conditions, but legal services are not up to the mark. There is no standardisation as the act mandates. I doubt the authorities even know the exact number of psychiatric patients in the state," he explained. A junior doctor at the IMH, speaking on condition of anonymity, said, "Awareness programmes were supposed to make people aware of the symptoms so that they would recognise the problem first and then take steps for proper treatment. But that has hardly happened. District committees, which are required under the act, have not been formed." 'Infrastructure woes' While IMH serves as the nodal institution for mental healthcare policies and regulations in Telangana, services are also provided at community mental healthcare centres (CMHCs) and govt hospitals in the state. IMH currently houses nearly 200 patients in the three wards - discharge, non-discharge, and open - of whom around 100 are ready to be discharged. However, their families are reluctant to take them back owing to post-discharge chronic mental illness. Patients in all these wards were affected during the recent food poisoning incident that claimed the life of a destitute person and left 92 others ill. In a report on June 11, TOI pointed out how IMH is grappling with infrastructure woes and staff shortages, thereby impacting patient care. While estimates say there are around eight lakh Psychiatric patients in Telangana, there are only about 600 mental health professionals, which is insufficient to meet growing needs. Officials refute claims A 2023 report by the Parliamentary Standing Committee on Health and Family Welfare highlighted that Telangana has only 50 to 60 accredited clinical psychologists, out of the total 2,840 in India. A senior official at the IMH, however, refuted the claims. "The state mental health authority (SMHA) is functioning smoothly and is regularly taking care of patients' rehabilitation through services of an NGO. Furthermore, awareness activities and other provisions of the act will be implemented soon."
Indian Express
6 hours ago
- Indian Express
Gurugram engineer falls asleep at the wheel, rams into 2 men: How sleeplessness affects your brain
Increasingly, we are hearing reports of people falling asleep while driving with terrible consequences as they hit unsuspecting people and even endanger their own lives. The latest case is of a Gurugram-based civil engineer, who was arrested for ramming into two men, including a law student, after he fell asleep while behind the wheel. Falling asleep at the wheel is a dangerous consequence of a fatigued or sleep-deprived brain. 'When we are sleep-deprived, the brain experiences 'microsleeps' — brief, involuntary episodes of sleep that can last a few seconds. During these moments, a driver can lose awareness and control, even with eyes open. The brain's prefrontal cortex, responsible for attention, decision-making, and alertness, becomes less active, impairing our ability to stay focused or respond quickly to road conditions,' says Dr Vinit Suri, senior consultant, Neurology, Indraprastha Apollo Hospitals, Delhi. The brain's sleep-wake cycle, governed by the circadian rhythm, also plays a critical role. Driving during low circadian alertness periods — such as late at night or early morning — increases the risk of drowsiness. 'Neurochemicals like adenosine, which build up during waking hours, signal sleep pressure to the brain; without rest, this pressure continues to mount, further weakening alertness. The reticular activating system (RAS), which helps keep us awake, starts to underperform when fatigued, making it harder to stay aroused. At the same time, the thalamus — a relay centre for sensory and motor signals — becomes less responsive, reducing awareness of surroundings,' explains Dr Suri. Drowsiness also suppresses activity in the brain's region responsible for vigilance and perception. 'Furthermore, a monotonous driving environment with little stimulation accelerates the decline in brain alertness. In essence, when the brain is too tired, its ability to prioritize staying awake over sleep fails, making it override even conscious efforts to stay alert,' says Dr Suri. A night's lack of sleep of less than six hours has been found to impair vigilance, reduce reaction time and decrease decision-making abilities in a similar way to alcohol consumption, according to Dr Aditya Gupta, Director, Neurosurgery & Cyberknife, Artemis Hospital, Gurugram. What are warning signs? Warning signs like frequent yawning, heavy eyelids, or drifting lanes should never be ignored. 'To prevent such cognitive shutdowns while driving, adequate sleep, regular breaks and avoiding driving during drowsy hours are essential. Fatigue behind the wheel is not a sign of weakness — it is a neurological warning that must be taken seriously,' he says. Patients with obstructive sleep apnoea may also have excessive daytime drowsiness, resulting in naps while driving and hence a history of heavy snoring should be taken, and if required, a sleep study too. What should you watch out for? 'We also caution against too much dependence on stimulants such as coffee or energy drinks. These can give a transient boost to alertness but cannot substitute for the brain's requirement for sleep,' says Dr Gupta. When their action wears off, sleep can hit one suddenly and uncontrollably. To avoid drowsy driving, he suggests getting 7–8 hours of sleep prior to long driving, resting breaks every two hours and not driving during the circadian low points. 'In the event of extreme exhaustion, the only solution is to stop and take a rest,' he adds.
The Hindu
16 hours ago
- The Hindu
Aurobindo recalling over 4,600 bottles of pain relieving tablets in U.S.
Generic drugmaker Aurobindo Pharma is recalling 4,608 bottles of pain relieving drug Acetaminophen Tablets, 325 mg, in the U.S. They are 100-count bottles and being recalled due to deviations from current Good Manufacturing Practices (cGMP), the U.S. Food and Drug Administration (U.S. FDA) said. Specially it is 'due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets),' the regulator said in its latest enforcement report. It is a voluntary recall and initiated by Aurobindo Pharma USA Inc., a subsidiary of the Hyderabad-based drugmaker, on May 22.
